News
Intravenous (IV) Iron Drugs Market Valued at US$ 3.7 Bn in 2025, Forecast at US$ 6.6 Bn by 2032
The Intravenous (IV) Iron Drugs Market has emerged as a critical segment within the global pharmaceutical and therapeutics landscape, driven by the rising burden of
Persistence Market Research
February 9, 2026